申请人:Bristol-Myers Squibb Company
公开号:US20130143843A1
公开(公告)日:2013-06-06
The present invention provides compounds of Formula (I):
or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.
本发明提供了以下式(I)的化合物:
或其立体异构体,或其药学上可接受的盐,其中所有变量如本文所定义。这些化合物是单酰基甘油酰基转移酶2(MGAT2)抑制剂,可用作药物。